Jeffrey S. Parkin

Array ( [id] => 648871 [patent_doc_number] => 07115363 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-03 [patent_title] => 'Retrovirus capable of causing AIDS, means and methods for detecting it in vitro' [patent_app_type] => utility [patent_app_number] => 08/470489 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 16782 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115363.pdf [firstpage_image] =>[orig_patent_app_number] => 08470489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4080017 [patent_doc_number] => 06162439 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Human immunodeficiency virus type 2 (HIV-2) polypeptides and methods of producing them' [patent_app_type] => 1 [patent_app_number] => 8/466707 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7080 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162439.pdf [firstpage_image] =>[orig_patent_app_number] => 466707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4342786 [patent_doc_number] => 06214347 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Multideterminant peptides that elicit helper T-lymphocyte, cytotoxic T lymphocyte and neutralizing antibody responses against HIV-1' [patent_app_type] => 1 [patent_app_number] => 8/455685 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 13 [patent_no_of_words] => 19025 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214347.pdf [firstpage_image] =>[orig_patent_app_number] => 455685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046687 [patent_doc_number] => 05932218 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Multideterminant peptides eliciting helper T-lymphocyte, cytotoxic T-lymphocyte, and neutralizing antibody responses against HIV-1' [patent_app_type] => 1 [patent_app_number] => 8/455625 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 49 [patent_no_of_words] => 22332 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932218.pdf [firstpage_image] =>[orig_patent_app_number] => 455625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4057839 [patent_doc_number] => 05866137 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Self-assembled, non-infectious, non-replicating; immunogenic retrovirus-like particles comprising modified HIV genomes devoid of long terminal repeats and chimeric envelope glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/453745 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4693 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866137.pdf [firstpage_image] =>[orig_patent_app_number] => 453745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046882 [patent_doc_number] => 05912338 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Nucleic acids encoding self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV genomes and chimeric envelope glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/452520 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4832 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912338.pdf [firstpage_image] =>[orig_patent_app_number] => 452520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4338722 [patent_doc_number] => 06284254 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mutants' [patent_app_type] => 1 [patent_app_number] => 8/453304 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21980 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284254.pdf [firstpage_image] =>[orig_patent_app_number] => 453304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766623 [patent_doc_number] => 05849475 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Immunoassay diagnostic kit containing antigens derived from self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV genomes and chimeric envelope glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/452503 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4697 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849475.pdf [firstpage_image] =>[orig_patent_app_number] => 452503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1017817 [patent_doc_number] => 06890710 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication' [patent_app_type] => utility [patent_app_number] => 08/444994 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 14889 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890710.pdf [firstpage_image] =>[orig_patent_app_number] => 08444994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1403762 [patent_doc_number] => 06538127 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Synthetic HIV-2 envelope genes containing modifications that lead to optimized expression in bacteria' [patent_app_type] => B1 [patent_app_number] => 08/443530 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 35 [patent_no_of_words] => 8000 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538127.pdf [firstpage_image] =>[orig_patent_app_number] => 08443530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186726 [patent_doc_number] => 06153377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Synthetic DNA derived recombinant HIV antigens' [patent_app_type] => 1 [patent_app_number] => 8/443961 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 35 [patent_no_of_words] => 7939 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153377.pdf [firstpage_image] =>[orig_patent_app_number] => 443961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777761 [patent_doc_number] => 05817792 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'DNA sequences encoding HIV-1 envelope muteins containing hypervariable domain deletions' [patent_app_type] => 1 [patent_app_number] => 8/441356 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 9 [patent_no_of_words] => 10887 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817792.pdf [firstpage_image] =>[orig_patent_app_number] => 441356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855148 [patent_doc_number] => 05792459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'HIV-1 envelope muteins lacking hypervariable domains' [patent_app_type] => 1 [patent_app_number] => 8/441184 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 10810 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792459.pdf [firstpage_image] =>[orig_patent_app_number] => 441184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1487414 [patent_doc_number] => 06428952 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies' [patent_app_type] => B1 [patent_app_number] => 08/424631 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5731 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428952.pdf [firstpage_image] =>[orig_patent_app_number] => 08424631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535748 [patent_doc_number] => 06337179 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Methods and kits for detecting antibodies against an HIV variant' [patent_app_type] => B1 [patent_app_number] => 08/423477 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 12441 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337179.pdf [firstpage_image] =>[orig_patent_app_number] => 08423477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4052651 [patent_doc_number] => 05863542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts' [patent_app_type] => 1 [patent_app_number] => 8/417210 [patent_app_country] => US [patent_app_date] => 1995-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 128 [patent_figures_cnt] => 175 [patent_no_of_words] => 55809 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863542.pdf [firstpage_image] =>[orig_patent_app_number] => 417210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349318 [patent_doc_number] => 06291227 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Nucleic acids containing modified human immunodeficiency virus genomes devoid of long terminal repeats encoding non-infectious, replication-deficient, immunogenic retrovirus-like particles' [patent_app_type] => 1 [patent_app_number] => 8/401355 [patent_app_country] => US [patent_app_date] => 1995-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9370 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291227.pdf [firstpage_image] =>[orig_patent_app_number] => 401355 [rel_patent_id] =>[rel_patent_doc_number] =>)